CEO: Ted W. Love

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.


Key numbers

Market Capitalization:4172582341
Shares Outstanding: 60940300
Float: 59588400
Next Earning Date:2020-08-05
TTm EPS: -4.8794
TTm Dividend Rate:
200 days moving average:66.29
50 days moving average: 68.28
One day percent Change: -2.91



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,